April 25, 2024
Market Now
Singapore’s Temasek sells W124b stake in Celltrion Healthcare
[DISCLOSURE] Ion Investments, a wholly-owned subsidiary of Singapore’s state investment firm Temasek, has sold 1,546,285 shares of Celltrion Healthcare (091990) at 124.1 billion won (US$110.98 million).
Its stake has declined to 9.41 percent from 10.53 percent.
By Hwang You-mee (glamazon@heraldcorp.com)
Its stake has declined to 9.41 percent from 10.53 percent.
By Hwang You-mee (glamazon@heraldcorp.com)
